23
Jul

Shire has signed a $225 million agreement to brighten its future in rare diseases, bolstering a major selling point for AbbVie as the two prepare for a $54.7 billion merger.

…read more

Source: Shire inks a $225M rare disease deal on the eve of life with AbbVie

    

0 No comments